Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2010 1
2011 1
2012 1
2013 2
2014 1
2015 2
2016 3
2017 1
2018 6
2019 6
2020 10
2021 18
2022 21
2023 14
2024 3

Text availability

Article attribute

Article type

Publication date

Search Results

74 results

Results by year

Filters applied: . Clear all
Page 1
Long-term efficacy, safety and neurotolerability of MATRix regimen followed by autologous transplant in primary CNS lymphoma: 7-year results of the IELSG32 randomized trial.
Ferreri AJM, Cwynarski K, Pulczynski E, Fox CP, Schorb E, Celico C, Falautano M, Nonis A, La Rosée P, Binder M, Fabbri A, Ilariucci F, Krampera M, Roth A, Hemmaway C, Johnson PW, Linton KM, Pukrop T, Gørløv JS, Balzarotti M, Hess G, Keller U, Stilgenbauer S, Panse J, Tucci A, Orsucci L, Pisani F, Zanni M, Krause SW, Schmoll HJ, Hertenstein B, Rummel M, Smith J, Thurner L, Cabras G, Pennese E, Ponzoni M, Deckert M, Politi LS, Finke J, Ferranti A, Cozens K, Burger E, Ielmini N, Cavalli F, Zucca E, Illerhaus G; IELSG32 study investigators. Ferreri AJM, et al. Among authors: thurner l. Leukemia. 2022 Jul;36(7):1870-1878. doi: 10.1038/s41375-022-01582-5. Epub 2022 May 13. Leukemia. 2022. PMID: 35562406 Clinical Trial.
Four versus six cycles of CHOP chemotherapy in combination with six applications of rituximab in patients with aggressive B-cell lymphoma with favourable prognosis (FLYER): a randomised, phase 3, non-inferiority trial.
Poeschel V, Held G, Ziepert M, Witzens-Harig M, Holte H, Thurner L, Borchmann P, Viardot A, Soekler M, Keller U, Schmidt C, Truemper L, Mahlberg R, Marks R, Hoeffkes HG, Metzner B, Dierlamm J, Frickhofen N, Haenel M, Neubauer A, Kneba M, Merli F, Tucci A, de Nully Brown P, Federico M, Lengfelder E, di Rocco A, Trappe R, Rosenwald A, Berdel C, Maisenhoelder M, Shpilberg O, Amam J, Christofyllakis K, Hartmann F, Murawski N, Stilgenbauer S, Nickelsen M, Wulf G, Glass B, Schmitz N, Altmann B, Loeffler M, Pfreundschuh M; FLYER Trial Investigators; German Lymphoma Alliance. Poeschel V, et al. Among authors: thurner l. Lancet. 2019 Dec 21;394(10216):2271-2281. doi: 10.1016/S0140-6736(19)33008-9. Lancet. 2019. PMID: 31868632 Clinical Trial.
Advances in Lymphoma Molecular Diagnostics.
Kos IA, Thurner L, Bittenbring JT, Christofyllakis K, Kaddu-Mulindwa D. Kos IA, et al. Among authors: thurner l. Diagnostics (Basel). 2021 Nov 23;11(12):2174. doi: 10.3390/diagnostics11122174. Diagnostics (Basel). 2021. PMID: 34943410 Free PMC article. Review.
Current Treatment Options in CLL.
Bewarder M, Stilgenbauer S, Thurner L, Kaddu-Mulindwa D. Bewarder M, et al. Among authors: thurner l. Cancers (Basel). 2021 May 19;13(10):2468. doi: 10.3390/cancers13102468. Cancers (Basel). 2021. PMID: 34069354 Free PMC article. Review.
IL-1RA Antibodies in Myocarditis after SARS-CoV-2 Vaccination.
Thurner L, Kessel C, Fadle N, Regitz E, Seidel F, Kindermann I, Lohse S, Kos I, Tschöpe C, Kheiroddin P, Kiblboeck D, Hoffmann MC, Bette B, Carbon G, Cetin O, Preuss KD, Christofyllakis K, Bittenbring JT, Pickardt T, Fischer Y, Thiele H, Baldus S, Stangl K, Steiner S, Gietzen F, Kerber S, Deneke T, Jellinghaus S, Linke A, Ibrahim K, Grabmaier U, Massberg S, Thilo C, Greulich S, Gawaz M, Mayatepek E, Meyer-Dobkowitz L, Kindermann M, Birk E, Birk M, Lainscak M, Foell D, Lepper PM, Bals R, Krawczyk M, Mevorach D, Hasin T, Keren A, Kabesch M, Abdul-Khaliq H, Smola S, Bewarder M, Thurner B, Böhm M, Pfeifer J, Klingel K. Thurner L, et al. N Engl J Med. 2022 Oct 20;387(16):1524-1527. doi: 10.1056/NEJMc2205667. Epub 2022 Sep 21. N Engl J Med. 2022. PMID: 36130012 Free PMC article. No abstract available.
The riddle of lymphoma BCR-antigenes.
Thurner L, Hartmann S, Preuss KD, Bewarder M. Thurner L, et al. Oncotarget. 2018 Nov 9;9(88):35805-35806. doi: 10.18632/oncotarget.26318. eCollection 2018 Nov 9. Oncotarget. 2018. PMID: 30533194 Free PMC article. No abstract available.
Autoantibodies against SUMO1-DHX35 in long-COVID.
Thurner L, Fadle N, Regitz E, Preuss KD, Neumann F, Cetin O, Schormann C, Hoffmann MC, Herr C, Kheiroddin P, Rixecker TM, Bals R, Muller S, Thurner B, Kessel C, Kabesch M, Bewarder M, Heyne K, Lensch C, Kos IA. Thurner L, et al. J Transl Autoimmun. 2022 Nov 20;5:100171. doi: 10.1016/j.jtauto.2022.100171. eCollection 2022. J Transl Autoimmun. 2022. PMID: 36425003 Free PMC article.
Epigastric Pain After COVID-19 Vaccination.
Casper M, Thurner L, Holz R, Krawczyk M, Link A. Casper M, et al. Among authors: thurner l. Am J Gastroenterol. 2022 Mar 1;117(3):371. doi: 10.14309/ajg.0000000000001609. Am J Gastroenterol. 2022. PMID: 35020675 No abstract available.
Role of Specific B-Cell Receptor Antigens in Lymphomagenesis.
Thurner L, Hartmann S, Neumann F, Hoth M, Stilgenbauer S, Küppers R, Preuss KD, Bewarder M. Thurner L, et al. Front Oncol. 2020 Dec 9;10:604685. doi: 10.3389/fonc.2020.604685. eCollection 2020. Front Oncol. 2020. PMID: 33363034 Free PMC article. Review.
74 results